+Compare
XXII
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
6.52M

XXII 22nd Century Group Forecast, Technical & Fundamental Analysis

a plant biotechnology company

Industry Tobacco
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for XXII with price predictions
07:00 PM EST Dec 04, 2023

XXII's RSI Indicator ascending out of oversold territory

The RSI Indicator for XXII moved out of oversold territory on November 29, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 43 similar instances when the indicator left oversold territory. In of the 43 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 67 cases where XXII's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +4 3-day Advance, the price is estimated to grow further. Considering data from situations where XXII advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

XXII may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XXII declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XXII entered a downward trend on December 05, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.481) is normal, around the industry mean (62.498). P/E Ratio (0.000) is within average values for comparable stocks, (25.328). XXII's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (5.368). XXII's Dividend Yield (0.000) is considerably lower than the industry average of (0.059). P/S Ratio (0.041) is also within normal values, averaging (42.558).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. XXII’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XXII’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 19.18B. The market cap for tickers in the group ranges from 160.39K to 146B. PM holds the highest valuation in this group at 146B. The lowest valued company is VHUB at 160.39K.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was 2%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was -6%. KAVL experienced the highest price growth at 17%, while ISPR experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was -52%. For the same stocks of the Industry, the average monthly volume growth was -38% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 63
Price Growth Rating: 56
SMR Rating: 63
Profit Risk Rating: 85
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

XXII is expected to report earnings to fall 11.37% to -7 cents per share on August 08

22nd Century Group XXII Stock Earnings Reports
Q2'23
Est.
$-0.07
Q1'23
Missed
by $0.01
Q4'22
Missed
by $0.06
Q3'22
Est.
$-0.06
Q2'22
Missed
by $0.01
The last earnings report on May 09 showed earnings per share of -7 cents, missing the estimate of -7 cents. With 743.14K shares outstanding, the current market capitalization sits at 6.52M.
A.I. Advisor
published General Information

General Information

a plant biotechnology company

Industry Tobacco

Profile
Fundamentals
Details
Industry
Miscellaneous
Address
500 Seneca Street
Phone
+1 716 270-1523
Employees
198
Web
https://www.xxiicentury.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EOLS9.930.05
+0.51%
Evolus
VYX15.47-0.06
-0.39%
NCR Voyix Corp
JWEL2.86-0.06
-2.05%
Jowell Global Ltd
INO0.40-0.01
-2.30%
Inovio Pharmaceuticals
AZPN195.03-7.26
-3.59%
Aspen Technology

XXII and

Correlation & Price change

A.I.dvisor tells us that XXII and UVV have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XXII and UVV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XXII
1D Price
Change %
XXII100%
+1.08%
UVV - XXII
16%
Poorly correlated
+1.80%
BTI - XXII
14%
Poorly correlated
-1.22%
TPB - XXII
13%
Poorly correlated
-0.33%
PM - XXII
10%
Poorly correlated
-0.41%
VGR - XXII
9%
Poorly correlated
+0.74%
More

Groups containing XXII

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XXII
1D Price
Change %
XXII100%
+1.08%
Tobacco
(undefined stocks)
14%
Poorly correlated
+0.07%
miscellaneous
(undefined stocks)
13%
Poorly correlated
-1.64%